Probiodrug AG

New treatment for Alzheimer's, prevention of toxic pE-Abeta, QC-Inhibitor to enter Phase II, disease-modifying, dominant IP, no therapy yet

  • Stage Product In Development
  • Industry Biotechnology
  • Location Halle, SA, Deutschland
  • Currency USD
  • Founded July 1997
  • Employees 20
  • Website probiodrug.de

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free